SCHEMBL1374664

SCHEMBL1374664

Cc1cc(O)c(O)c(C(C)(C)C)c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.77
SMN1; SMN2 Q16637 5/20 0.77
CA2 P00918 4/20 0.77
POLB P06746 2/20 0.77
TYR P14679 2/20 0.77
HSPA5 P11021 1/20 0.61
SELL P14151 1/20 0.59
SELP P16109 1/20 0.59
SELE P16581 1/20 0.59
CYP2C9 P11712 5/20 0.59
CYP2C19 P33261 4/20 0.59
HIF1A Q16665 3/20 0.59
CA1 P00915 2/20 0.52
HSD17B10 Q99714 2/20 0.52
CYP2D6 P10635 1/20 0.52
MAPT P10636 3/20 0.50
ALOX15 P16050 3/20 0.50
CYP1A2 P05177 2/20 0.50
KDM4E B2RXH2 2/20 0.50
ATP2A2 P16615 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butylated Hydroxytoluene SCHEMBL453824 0.87 SMN1; SMN2 (1.00) ALDH1A1SMN1; SMN2CA2POLBTYR
Butylated Hydroxytoluene SCHEMBL3950 0.87 SMN1; SMN2 (1.00) ALDH1A1SMN1; SMN2CA2POLBTYR
Butylated Hydroxytoluene SCHEMBL7075597 0.85 SMN1; SMN2 (0.95) ALDH1A1SMN1; SMN2CA2POLBTYR
Butylated Hydroxytoluene SCHEMBL20660368 0.85 SMN1; SMN2 (0.95) ALDH1A1SMN1; SMN2CA2POLBTYR
Butylated Hydroxytoluene SCHEMBL864242 0.85 SMN1; SMN2 (0.95) ALDH1A1SMN1; SMN2CA2POLBTYR
Butylated Hydroxytoluene SCHEMBL4170581 0.85 SMN1; SMN2 (0.95) ALDH1A1SMN1; SMN2CA2POLBTYR
Butylated Hydroxytoluene SCHEMBL9343307 0.85 SMN1; SMN2 (0.95) ALDH1A1SMN1; SMN2CA2POLBTYR
Butylated Hydroxytoluene SCHEMBL11857289 0.85 SMN1; SMN2 (0.95) ALDH1A1SMN1; SMN2CA2POLBTYR
Butylated Hydroxytoluene SCHEMBL11859223 0.85 SMN1; SMN2 (0.95) ALDH1A1SMN1; SMN2CA2POLBTYR
Butylated Hydroxytoluene SCHEMBL9343306 0.85 SMN1; SMN2 (0.95) ALDH1A1SMN1; SMN2CA2POLBTYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021153943-A1 POLYMERIZATION CURING RATE-ADJUSTED COMPOSITION FOR HIGHLY REFRACTIVE EPISULFIDE-BASED OPTICAL MATERIAL AND METHOD FOR MANUFACTURING OPTICAL MATERIAL BY USING SAME 주식회사 케이오씨솔루션 2021-08-05 WO claimed
US-4196112-A ADDUCT OF A BUTADIENE POLYMER AN A,B-ACID, A CARBOCYCLIC ALCOHOL GELATION INHIBITOR, A HYDROPHILIC SOLVENT, A NEUTRALIZER NIPPON OIL CO., LTD. (JP) 1980-04-01 US claimed
US-4175068-A ADDUCT OF BUTADIENE AND UNSATURATED DICARBOXYLIC ACID, NEUTRALIZER NIPPON OIL CO., LTD. (JP) 1979-11-20 US claimed
US-12636325-B2 Probiotic compositions for treating and preventing colorectal cancer THE CHINESE UNIVERSITY OF HONG KONG (CN) 2026-05-26 US disclosed
US-20240316125-A1 PROBIOTIC COMPOSITIONS FOR TREATING AND PREVENTING COLORECTAL CANCER THE CHINESE UNIVERSITY OF HONG KONG (CN) 2024-09-26 US disclosed
US-11975034-B2 Probiotic compositions for treating and preventing colorectal cancer THE CHINESE UNIVERSITY OF HONG KONG (CN) 2024-05-07 US disclosed
CN-113226686-B Hard-coated molded resin and method for producing the same 哈利玛化成株式会社 2024-05-07 CN disclosed
CN-113165356-B Multilayer sheet and transfer material 哈利玛化成株式会社 2023-12-26 CN disclosed
US-20230158086-A1 PROBIOTIC COMPOSITIONS FOR TREATING AND PREVENTING COLORECTAL CANCER THE CHINESE UNIVERSITY OF HONG KONG (CN) 2023-05-25 US disclosed
CN-115702908-A Probiotic composition for the treatment and prevention of colorectal cancer 香港中文大学 2023-02-17 CN disclosed
WO-2023011591-A1 PROBIOTIC COMPOSITIONS FOR TREATING AND PREVENTING COLORECTAL CANCER THE CHINESE UNIVERSITY OF HONG KONG (CN) 2023-02-09 WO disclosed
US-4197226-A Water-soluble coating composition NIPPON OIL CO., LTD. (JP) 1980-04-08 US disclosed
US-4196113-A ADDUCT OF A BUTADIENE POLYMER AND AN A,B-ACID, A 1,2-DIHYDROQUINOLINE GELATING INHIBITOR, A HYDROPHILIC SOLVENT, A NEUTRALIZER NIPPON OIL CO., LTD. (JP) 1980-04-01 US disclosed
US-4196112-A ADDUCT OF A BUTADIENE POLYMER AN A,B-ACID, A CARBOCYCLIC ALCOHOL GELATION INHIBITOR, A HYDROPHILIC SOLVENT, A NEUTRALIZER NIPPON OIL CO., LTD. (JP) 1980-04-01 US disclosed
US-4176109-A CORROSION RESISTANCE, IMPACT RESISTANCE, ADHESIONN; ADDUCT OF BUTAC SOLVENT, NEUTRALIZER NIPPON OIL CO., LTD. (JP) 1979-11-27 US disclosed
US-4175068-A ADDUCT OF BUTADIENE AND UNSATURATED DICARBOXYLIC ACID, NEUTRALIZER NIPPON OIL CO., LTD. (JP) 1979-11-20 US disclosed
US-4171308-A ADDUCT OF A BUTADIENE POLYMER AND AN A,B-UNSATURATED CARBOXY ACID COMPOUND, NEUTRALIZED NIPPON OIL CO. LTD. (JP) 1979-10-16 US disclosed
US-4145501-A ADDUCT OF A LOW MOLECULAR WEIGHT BUTADIENE POLYMER AND AN UNSATURATED DICARBOXYLIC ACID COMPOUND, CORROSION RESISTANT, ADHESION, IMPACT RESISTANT NIPPON OIL CO., LTD. (JP) 1979-03-20 US disclosed
US-4050945-A METALLIC COMPOUND REACTANT, CHELATING COMPOUND REACTANT, BINDER SUZUKI YOSHIO 1977-09-27 US disclosed
US-3952023-A Method for preparing adduct of butadiene polymer or copolymer and α, β-ethylenically unsaturated dicarboxylic acid compound NIPPON OIL COMPANY LTD. (JA) 1976-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240316125-A1 PROBIOTIC COMPOSITIONS FOR TREATING AND PREVENTING COLORECTAL CANCER APC, FABP2, SLC10A2 ALDH1A1 1229/4885SMN1; SMN2 3691/4885CA2 1251/4885
US-11975034-B2 Probiotic compositions for treating and preventing colorectal cancer LCT, SI, APC ALDH1A1 2194/4885SMN1; SMN2 3985/4885CA2 699/4885
US-20230158086-A1 PROBIOTIC COMPOSITIONS FOR TREATING AND PREVENTING COLORECTAL CANCER APC, FABP2, SLC10A2 ALDH1A1 1229/4885SMN1; SMN2 3691/4885CA2 1251/4885
US-12636325-B2 Probiotic compositions for treating and preventing colorectal cancer LCT, SI, LDHA ALDH1A1 449/4885SMN1; SMN2 3817/4885CA2 707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.